A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias

Clinical Infectious Diseases

Volumn 71, Issue 15, 2020, Pages 756-761

  Zhao, Dahai ^a   Yao, Feifei ^b   Wang, Lijie ^c   Zheng, Ling ^a   Gao, Yongjun ^c   Ye, Jun ^a   Guo, Feng ^b   Zhao, Hui ^a   Gao, Rongbao ^c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Clinical features; Infectious diseases; Novel coronavirus pneumonia; Respiratory infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; HYDROXYBUTYRATE DEHYDROGENASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LOPINAVIR; MOXIFLOXACIN; RITONAVIR;

ABNORMAL LABORATORY RESULT; ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; CHEST TIGHTNESS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; COUGHING; DEMOGRAPHY; DIARRHEA; DISEASE DURATION; ENTEROVIRUS INFECTION; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; MALE; MIXED INFECTION; MYCOPLASMOSIS; NEUTROPHIL; OXYGEN THERAPY; PNEUMONIA; PRIORITY JOURNAL; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SORE THROAT; SPUTUM ANALYSIS; SYMPTOM; THORAX RADIOGRAPHY; THROAT CULTURE; VIRUS PNEUMONIA; BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTION; MIDDLE AGED; PANDEMIC; PATHOGENICITY; PROCEDURES; TRAVEL; VIROLOGY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; COUGH; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA; PNEUMONIA, VIRAL; TOMOGRAPHY, X-RAY COMPUTED; TRAVEL;

EID: 85082796640     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciaa247     Document Type: Article

References (30)

1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020. doi:10.1056/NEJMoa2001017
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020. doi:10.1016/S0140-6736(20)30183-5
3. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17:181-92.
4. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-76.
5. Ksiazek TG, Erdman D, Goldsmith CS, et al; SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348:1953-66.
6. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367:1814-20.
7. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020. doi:10.1016/S0140-6736(20)30211-7
8. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 2020. doi:10.1001/ jama.2020.1097
9. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med 2020. doi:10.1056/ NEJMoa2001316
10. González DA, Victora CG, Gonçalves H. The effects of season at time of birth on asthma and pneumonia in childhood and adulthood in a birth cohort in southern Brazil. Cad Saude Publica 2008; 24:1089-102.
11. Viasus D, Marinescu C, Villoslada A, et al; Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI). Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study. J Infect 2013; 67:185-93.
12. National health commission of China. Novel coronavirus pneumonia prevention and control program. 3rd ed. 2020. [inChinese]. Available at: http:// wwwnhcgovcn/xcs/zhengcwj/202001/470b128513fe46f086d79667db9f76a5/files /8faa1b85841f42e8a0febbea3d8b9cb2pdf
13. Song F, Shi N, Shan F, et al. Emerging coronavirus 2019-nCoV pneumonia. Radiology 2020; 200274. doi:10.1148/radiol.2020200274
14. Patel A, Jernigan DB, nCo VCDCRT: initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak-United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 2020;69:140-146.
15. Gao ZC. Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43:E001.
16. Lin YC, Dong SL, Yeh YH, et al. Emergency management and infection control in a radiology department during an outbreak of severe acute respiratory syndrome. Br J Radiol 2005; 78:606-11.
17. Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013; 368:2277-85.
18. Wang W, Qiu B, Li Q, Chen H, Xu W. CT onset of influenza A (H1N1) complicated with severe pneumonia in two typical cases. Panminerva Med 2010; 52:355-9.
19. Peiris JS, Yuen KY, Osterhaus AD, Stöhr K. The severe acute respiratory syndrome. N Engl J Med 2003; 349:2431-41.
20. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009; 106:3455-60.
21. Liu B, Zhang X, Deng W, et al. Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ. Cell Death Dis 2014; 5:e1440.
22. Younan P, Santos RI, Ramanathan P, et al. Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection. PLoS Pathog 2019; 15:e1008068.
23. Pfäfflin A, Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem 2009; 393:1473-80.
24. van den Brand JM, Haagmans BL, van Riel D, Osterhaus AD, Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 2014; 151:83-112.
25. Gao R, Bhatnagar J, Blau DM, et al. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. Am J Pathol 2013; 183:1258-68.
26. Gao R, Wang L, Bai T, Zhang Y, Bo H, Shu Y. C-reactive protein mediating immunopathological lesions: a potential treatment option for severe influenza A diseases. EBioMedicine 2017; 22:133-42.
27. Narasaraju T, Yang E, Samy RP, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011; 179:199-210.
28. Tang BM, Shojaei M, Teoh S, et al. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection. Nat Commun 2019; 10:3422.
29. Peiris JS, Chu CM, Cheng VC, et al; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361:1767-72.
30. Fowler RA, Lapinsky SE, Hallett D, et al; Toronto SARS Critical Care Group. Critically ill patients with severe acute respiratory syndrome. JAMA 2003; 290:367-73.